-
16.04.2013
Gene therapy with CDNF provides functional benefits in a rat model of Parkinson's disease
Read more
-
12.04.2013
Transformative healthcare - 2013 is a big year for Hermo Pharma
Read more
-
15.03.2013
Hermo Pharma a Finalist for the 2013 Red Herring Top 100 Europe Award
Read more
-
07.03.2013
CDNF patent granted in Japan
Read more
-
09.02.2013
Review on how antidepressants enhance neuronal plasticity
Read more
-
05.02.2013
Last patients completed treatment in amblyopia phase 2a clinical study
Read more
-
04.02.2013
Characterization of mammalian posttranslational modifications of GDNF
Read more
-
23.01.2013
CDNF patent granted in Australia
Read more
-
18.01.2013
Selection among Top 20 startup companies in Finland
Read more
-
14.11.2012
Update in the R&D pipeline
Read more
-
14.11.2012
Patient recruitment completed for HER-801 phase 2a clinical study
Read more
-
29.10.2012
Modulation of neuronal plasticity to treat neurodevelopmental disorders in adulthood
Read more
-
01.10.2012
Hermo Pharma a finalist in Rising Star Award competition
Read more
-
18.09.2012
Meet us at the Biotech in Europe Investor Forum or Biopartnering FutureEUROPE
Read more
-
07.08.2012
Meet us at the Nordic Congress of Ophthalmology in Helsinki
Read more
-
11.06.2012
Meet us at BIO 2012 in Boston
Read more
-
10.06.2012
NPAS4 gene regulates plasticity in adult visual cortex
Read more
-
04.05.2012
Meet us at BioEquity Europe 2012 Frankfurt
Read more
-
24.04.2012
Jonathan Knowles invests in Hermo Pharma's Series A round
Read more
-
13.03.2012
US Patent Office grants a patent on amblyopia therapy to Hermo Pharma
Read more
-
23.02.2012
First patients completed the amblyopia phase 2a study
Read more
-
02.01.2012
Fear erasure in mice requires synergy between antidepressant drugs and extinction training
Read more
-
09.12.2011
Hermo Pharma selected as one of the 30 most promising Finnish growth companies
Read more
-
09.11.2011
Notice of Allowance for U.S. patent covering amblyopia treatment
Read more
-
03.11.2011
License agreement on sales of recombinant CDNF protein for research use
Read more
-
29.09.2011
CDNF is both neuroprotective and neurorestorative in MPTP mouse model of Parkinson's disease
Read more
-
20.09.2011
Professor Barry Hoffer comments on preclinical CDNF data from rodent models of Parkinson's disease
Read more
-
29.08.2011
Tekes grants Hermo Pharma funding for clinical development of Amblyopia in adults Therapy
Read more
-
29.08.2011
Michael J. Fox Foundation awards additional $188,818 to professor Mart Saarma for therapeutic development for Parkinson’s disease
Read more
-
15.08.2011
Sigrid Booms joins Hermo Pharma as Director of Clinical Development
Read more
-
24.05.2011
Position available for Director of Clinical Development
Read more
-
21.04.2011
Hermo Pharma closes first industrial partnership agreement with major pharmaceutical company
Read more
-
17.03.2011
CTA approval for HER-801 phase 2a study
Read more
-
07.03.2011
Meet us at BIO-Europe Spring in Milan
Read more
-
09.02.2011
Tekes grants funding for preclinical development of CDNF for Parkinson's disease
Read more
-
31.01.2011
Data for chronic infusion of CDNF in rat model of Parkinson's disease
Read more
-
27.01.2011
Clinical Trial Application for adult amblyopia filed
Read more
-
10.01.2011
Syndecan-3 identified as a novel receptor for GDNF
Read more
-
03.01.2011
An epigenetic mechanism involved in adult visual cortex plasticity
Read more
-
16.12.2010
Mart Saarma nominated in EMBO Council
Read more
-
09.12.2010
Hermo Pharma at Bio-Europe 2010
Read more
-
03.12.2010
Pekka Männistö Receives Honorary Doctorate
Read more
-
09.11.2010
Jonathan Knowles receives Scrip Lifetime Achievement Award 2010
Read more
-
03.11.2010
MANF has a unique mechanism to rescue apoptotic neurons
Read more
-
06.10.2010
Lehdistötiedote 6.10.2010: Michael J. Fox apuraha
Read more
-
06.10.2010
Michael J. Fox Foundation awards a grant to support development of CDNF
Read more
-
05.10.2010
CDNF EPO patent granted to Hermo Pharma
Read more
-
05.10.2010
Growth mentoring by Culminatum Innovation
Read more
-
11.08.2010
Hermo Pharma acquires rights to the CDNF technology
Read more
-
01.04.2010
Tekes grants Hermo Pharma funding for preclinical development of HER-801
Read more
-
01.03.2010
Hermo Pharma selected in Tekes' Pharma Business and Marketing Mentoring Program
Read more
-
21.02.2010
The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
Read more
-
11.02.2010
Tekes awards Hermo Pharma a grant for business development
Read more
-
03.01.2010
Hermo Pharma Ltd. announces appointments for Board of Directors
Read more
-
20.12.2009
Role of Brain-Derived Neurotrophic Factor in the aetiology of depression: implications for pharmacological treatment
Read more
-
16.12.2009
Hermo Pharma Ltd. closes first round of financing
Read more
-
15.12.2009
Executive management nominations
Read more
-
15.11.2009
Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors
Read more
-
10.11.2009
Novel CDNF/MANF family of neurotrophic factors (new review article)
Read more
-
01.11.2009
Neural plasticity and recovery from depression
Read more
-
25.09.2009
Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by anti-Parkinsonian drug therapy in vivo
Read more
-
17.09.2009
Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals
Read more
-
03.08.2009
Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease
Read more
-
15.07.2009
Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons
Read more
-
30.06.2009
Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells
Read more
-
25.06.2009
Inhibition of Acyl-coenzyme A: Cholesterol Acyl Transferase modulates amyloid precursor protein trafficking in the early secretory pathway
Read more
-
05.05.2009
Tekes awards Hermo Pharma a grant for initiation of business activities
Read more
-
01.02.2009
Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling
Read more
-
11.01.2009
Neuronal regulation of immune responses in the central nervous system
Read more
-
11.01.2009
Novel N-terminal cleavage of APP precludes Aβ generation in ACAT-defective AC29 cells
Read more
-
02.01.2009
The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional
Read more
-
01.01.2009
Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons
Read more
-
01.01.2009
MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain
Read more
-
03.08.2008
The antidepressant fluoxetine restores plasticity in the adult visual cortex
Read more
|
